Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Bioarchitech

Bioarchitech
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$57.6K LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of oncolytic viruses designed to treat cancer. The company's oncolytic viruses are developed with improved therapeutic amplification at the tumor site and have the ability to survive in the body's circulation to target tumor metastases, which are the main cause of morbidity and mortality, enabling patients to begin treatment more quickly, resulting in a higher likelihood of more successful tumor treatment.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • BioEscalator, Innovation Building
  • University of Oxford, Roosevelt Drive
  • Oxford OX3 7FZ
  • England, United Kingdom
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Bioarchitech’s full profile, request a free trial.

Bioarchitech Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 03-Apr-2019 $57.6K 00000 00.000 Completed Startup
4. Early Stage VC 20-Oct-2017 00000 00000 00.000 Completed Startup
3. Grant 01-Dec-2016 00000 00000 Completed Startup
2. Early Stage VC 17-Mar-2016 $70.9K $226K 00000 Completed Startup
1. Early Stage VC 13-Aug-2015 $155K $155K 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Bioarchitech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 50,000 $0.001315 $1.32 $1.32 1x $1.32 5.29%
Ordinary 165,750 $0.001315 $0.79 $0.79 1x $0.79 17.53%
To view this company’s complete Cap Table, request access »

Bioarchitech Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Innovate UK Government 000 0000 000000 0
Oxford Technology Management Venture Capital Minority 000 0000 000000 0

Bioarchitech Executive Team (4)

Name Title Board
Seat
Contact
Info
Geoffrey Hale Ph.D Board Member & Managing Director
Kevin Maskell Co-Founder & Research Director
Hannah Chen Co-Founder

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

Bioarchitech Board Members (2)

Name Representing Role Since Contact
Info
Geoffrey Hale Ph.D Bioarchitech Board Member & Managing Director 000 0000

1 Former Board Member

You’re viewing 1 of 2 board members. Get the full list »